ExodusPoint Capital Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $238K | Sell |
26,125
-53,235
| -67% | -$485K | ﹤0.01% | 1213 |
|
|
2025
Q1 | $631K | Sell |
79,360
-60,388
| -43% | -$480K | 0.01% | 1001 |
|
|
2024
Q4 | $759K | Buy |
+139,748
| New | +$759K | 0.01% | 941 |
|
|
2024
Q2 | – | Sell |
-102,305
| Closed | -$1.92M | – | 1785 |
|
|
2024
Q1 | $1.92M | Buy |
102,305
+74,341
| +266% | +$1.39M | 0.01% | 612 |
|
|
2023
Q4 | $606K | Sell |
27,964
-2,107
| -7% | -$45.7K | ﹤0.01% | 909 |
|
|
2023
Q3 | $619K | Buy |
+30,071
| New | +$619K | 0.01% | 1120 |
|
|
2023
Q1 | – | Sell |
-14,116
| Closed | -$538K | – | 1981 |
|
|
2022
Q4 | $538K | Sell |
14,116
-55,117
| -80% | -$2.1M | 0.01% | 1113 |
|
|
2022
Q3 | $2.71M | Sell |
69,233
-73,722
| -52% | -$2.89M | 0.04% | 615 |
|
|
2022
Q2 | $4.62M | Sell |
142,955
-27,955
| -16% | -$903K | 0.06% | 411 |
|
|
2022
Q1 | $5.66M | Buy |
+170,910
| New | +$5.66M | 0.07% | 306 |
|
|
2021
Q4 | – | Sell |
-52,134
| Closed | -$2.31M | – | 2478 |
|
|
2021
Q3 | $2.31M | Buy |
52,134
+21,554
| +70% | +$955K | 0.03% | 633 |
|
|
2021
Q2 | $1.74M | Buy |
30,580
+26,433
| +637% | +$1.5M | 0.02% | 693 |
|
|
2021
Q1 | $310K | Buy |
4,147
+1,752
| +73% | +$131K | ﹤0.01% | 1598 |
|
|
2020
Q4 | $207K | Sell |
2,395
-20,915
| -90% | -$1.81M | ﹤0.01% | 1643 |
|
|
2020
Q3 | $1.43M | Sell |
23,310
-14,476
| -38% | -$885K | 0.03% | 481 |
|
|
2020
Q2 | $1.57M | Buy |
+37,786
| New | +$1.57M | 0.04% | 509 |
|
|
2019
Q3 | – | Sell |
-3,402
| Closed | -$623K | – | 1568 |
|
|
2019
Q2 | $623K | Buy |
+3,402
| New | +$623K | 0.02% | 361 |
|